openPR Logo
Press release

Immunoglobulin Market Size, Share, Industry, Forecast and Outlook (2024-2031)

02-27-2024 11:10 AM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

DataM Intelligence

DataM Intelligence

Immunoglobulin Market

Global Immunoglobulin Market Expected to Reach US$ YY Million by 2030, Driven by Increasing Demand for Innovative Therapies

The global immunoglobulin market, valued at US$ YY million in 2022, is projected to witness significant growth, reaching US$ YY million by 2030, with a CAGR of YY% during the forecast period 2024-2031. Immunoglobulins, also known as antibodies, are vital glycoproteins produced by plasma cells, playing a crucial role in humoral immune responses against various pathogens and substances.

Different types of immunoglobulins, classified by isotype, exhibit diverse functions and antigen responses, thereby offering a broad spectrum of therapeutic applications. The market covers segments such as type, form, application, route of administration, and end-user across regions including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

Market Dynamics: Drivers

The market is primarily driven by the escalating demand for innovative immunoglobulins tailored to address unmet needs in disease management and treatment. Regulatory approvals, such as those from the U.S. Food and Drug Administration (FDA), continue to bolster adoption rates. Notably, recent approvals include EPKINLYTM by AbbVie, the first T-cell engaging bispecific antibody for certain lymphomas, and Thermo Fisher Scientific's EXENT Solution for monoclonal gammopathies.

Moreover, the expansion of immunoglobulin applications beyond traditional uses for conditions like primary immunodeficiency and autoimmune diseases is fostering market growth. Collaborations and partnerships, such as the one between Sanofi and IGM Biosciences to develop IgM antibody agonists, further enhance the market landscape.

To know more Insights Download Sample: https://www.datamintelligence.com/download-sample/immunoglobulin-market

Market Dynamics: Restraints

Despite the promising growth trajectory, the market faces challenges due to severe and rare side effects associated with immunoglobulins. Adverse reactions such as transfusion-related acute lung injury (TRALI) and acute renal failure pose significant concerns, potentially impeding market expansion.

Market Segmentation

The global immunoglobulin market is segmented based on type, form, application, route of administration, end-user, and region. Notably, the immunoglobulin G (IgG) segment dominates the market, constituting approximately 52.1% of the market share. Within this segment, IgG1, IgG2, IgG3, and IgG4 types offer distinct therapeutic benefits, with intravenous administration being a common modality.

Geographical Share

North America holds the largest share of the global immunoglobulin market, accounting for approximately 41.1% of the market share. The region's dominance is attributed to the presence of key players like Takeda Pharmaceuticals Inc. and robust research activities aimed at advancing immunoglobulin therapies. The United States, in particular, witnesses increasing adoption rates fueled by rising prevalence rates of immunodeficiency disorders.

Market Players

Key players in the global immunoglobulin market include Takeda Pharmaceuticals Inc., CSL Limited, Octapharma AG, Kedrion Biopharma Inc., Grifols, S.A., ADMA Biologics, Inc., Pfizer Inc., Kamada Pharmaceuticals, Cygnus Technologies, and Emergent BioSolutions Canada Inc.

Related Reports:

color blindness market https://www.datamintelligence.com/research-report/color-blindness-market
typhoid fever market https://www.datamintelligence.com/research-report/typhoid-fever-market
alpha 1 antitrypsin deficiency therapy market https://www.datamintelligence.com/research-report/alpha-1-antitrypsin-deficiency-therapy-market
next generation immunotherapies market https://www.datamintelligence.com/research-report/next-generation-immunotherapies-market
idiopathic hypersomnia treatment market https://www.datamintelligence.com/research-report/idiopathic-hypersomnia-treatment-market
persistent epithelial defect treatment market https://www.datamintelligence.com/research-report/persistent-epithelial-defect-treatment-market

Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immunoglobulin Market Size, Share, Industry, Forecast and Outlook (2024-2031) here

News-ID: 3401331 • Views:

More Releases from DataM Intelligence 4Market Research

United States Artemisinin Combination Therapy Market is expected to reach US$ 1,061 million by 2031 | Major key players - Novartis AG, Ajanta Pharma, Schwitz Biotech.
United States Artemisinin Combination Therapy Market is expected to reach US$ 1, …
Market Size and Growth: The Global Artemisinin Combination Therapy Market size reached US$ 547 million in 2023 and is expected to reach US$ 1,061 million by 2031, growing at a CAGR of 8.8% during the forecast period 2024-2031. The Market is driven by the rising prevalence of malaria in tropical regions and increasing adoption of effective combination therapies for drug-resistant strains. According to DataM Intelligence To Download a Free Sample PDF (Use
United States Biosimilars Market is expected to reach US$ 171.79 billion by 2033 | Top key players - Amgen Inc., Pfizer Inc., Biogen.
United States Biosimilars Market is expected to reach US$ 171.79 billion by 2033 …
Market Size and Growth: The Global Biosimilars Market size reached US$ 22.58 billion in 2024 and is expected to reach US$ 171.79 billion by 2033, growing at a CAGR of 25.5% during the forecast period 2025-2033. The Market is driven by rising demand for cost-effective biologic therapies, increasing patent expirations of branded drugs, and expanding regulatory approvals worldwide. According to DataM Intelligence To Download a Free Sample PDF (Use Corporate email ID
United States Kidney Transplant Market is expected to reach US$ 10.99 Billion by 2033 | Top key players - XVIVO, Paragonix Technologies, Bridge to Life Ltd.
United States Kidney Transplant Market is expected to reach US$ 10.99 Billion by …
Market Size and Growth: The Kidney Transplant Market size reached US$ 7.91 Billion in 2024 and is expected to reach US$ 10.99 Billion by 2033, growing at a CAGR of 3.7% during the forecast period 2025-2033. The Market is driven by the rising prevalence of chronic kidney diseases, increasing organ donation awareness, and advancements in transplant technologies. According to DataM Intelligence To Download a Free Sample PDF (Use Corporate email ID to
United States Functional Additives and Barrier Coatings Market is expected to reach US$ 65.0 billion by 2031 | Top key players - Dupont, BASF SE, Solvay SA.
United States Functional Additives and Barrier Coatings Market is expected to re …
Market Size and Growth: The Global Functional Additives and Barrier Coatings Market size reached US$ 42.2 billion in 2022 and is expected to reach US$ 65.0 billion by 2031, growing with a CAGR of 5.6% during the forecast period 2024-2031. The Market growth is driven by rising demand for sustainable and high-performance packaging solutions, along with increasing use of barrier coatings to enhance product shelf life and protection. According to DataM

All 5 Releases


More Releases for IgG

Emerging Trends to Reshape the Mammalian Polyclonal Immunoglobulin G (IgG) Antib …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size for mammalian polyclonal immunoglobulin g (IgG) antibody has shown significant growth. The value of the market is anticipated to increase from $1.31 billion in 2024
Major Market Shift in Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Indus …
What Is the Forecasted Market Size and Growth Rate for the Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market? The market size of mammalian polyclonal immunoglobulin g (IgG) antibody has seen a robust expansion in the past few years. The growth is projected to surge from $1.31 billion in 2024 to $1.42 billion in 2025, with a compound annual growth rate (CAGR) of 8.2%. The noteworthy expansion during the historical term can
IgG Antibody Market Growth: The Rise of Mammalian Polyclonal Solutions
The Business Research Company recently released a comprehensive report on the Global Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something
Harnessing Immunity: The Role of Mammalian Polyclonal IgG Antibodies
The Business Research Company recently released a comprehensive report on the Global Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's,
Mammalian Polyclonal IgG Antibody Market, Mammalian Polyclonal IgG Antibody Mark …
"According to the research report, the global inspection machines market was valued at USD 845.21 million in 2022 and is expected to reach USD 1,437.59 million by 2032, to grow at a CAGR of 5.5% during the forecast period." Request Our Free Sample Report for Inspection Machines Market Insights and Emerging Trends @ https://www.polarismarketresearch.com/industry-analysis/inspection-machines-market/request-for-sample Report Overview Polaris Market Research, a leading global market research and consulting company, has recently published its latest report
Goat Anti-Mouse IgG Market- Projections & Estimations, Forecast by 2020-2029
The report includes vital information on the current size and projected growth of the entire market for goat anti-mouse igg and its relevant sectors. It also includes market characteristics, top suppliers, consumer preference patterns, and geographic market potential. Dhirtek Business Research and Consulting created this study using both primary and secondary sources. Primary sources included core and associated industry specialists, as well as those associated with service providers, deployment engineers,